Jinkun Zhang - Concepedia

Author

Jinkun Zhang

Arena Pharmaceuticals (United States)ORCID

Also Known As

J K Zhang, J Zhang, Jie Wu, Jin-Kun Zhang, Jinkun Zhang, Zhang Jin-kun, Zhang Jinkun, Zhang, Jinkun

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Arena Pharmaceuticals (United States)Shantou University Medical College Shantou University University of California San Diego Université de Lorraine

About

Jinkun Zhang is an author at Arena Pharmaceuticals (United States) specializing in medicine, immunology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	621
2	Engineering	3	3	66
3	Health Sciences	1	1	531
4	Natural Sciences	1	1	38
5	Public Health	1	1	11

Jinkun Zhang

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study Patrick M. O’Neil, Steven R. Smith, Neil J. Weissman, Obesity Cardiometabolic RiskPharmacotherapyObesityMetabolic SyndromeBody Composition	2012	531
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis William J. Sandborn, Laurent Peyrin‐Biroulet, Jinkun Zhang, Gastroenterology	2019	223
Lorcaserin, A 5-HT<sub>2C</sub>Receptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure Corby K. Martin, Leanne M. Redman, Jinkun Zhang, The Journal of Clinical Endocrinology & Metabolism	2010	134
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study Séverine Vermeire, Michael Chiorean, Julián Panés, Journal of Crohn s and Colitis	2021	100
Sensitive Nonenzymatic Electrochemical Glucose Detection Based on Hollow Porous NiO Gege He, Liangliang Tian, Yan‐Hua Cai, Nanoscale Research Letters	2018	56
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial Fernando Torres, Harrison W. Farber, Arsen Ristić, European Respiratory Journal	2019	45
A miR-1231 binding site polymorphism in the 3′UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility Chunxiao Zhou, Qiang Yu, Lei Chen, Gene MedicineNatural SciencesImmunologyGene ExpressionPathology	2012	38
Improving purity of blasting vibration signals using advanced Empirical Mode Decomposition and Wavelet packet technique Zilong Zhou, Jinkun Zhang, Ruishan Cheng, Applied Acoustics Vibration EnvironmentEngineeringWavelet Packet TechniqueNondestructive TestingGround Vibration	2022	30
Insertion/Deletion Polymorphisms in the Promoter Region of BRM Contribute to Risk of Hepatocellular Carcinoma in Chinese Populations Xueren Gao, Moli Huang, Limin Liu, PLoS ONE	2013	25
Identification of polymorphisms associated with hypertriglyceridemia and prolonged survival induced by bexarotene in treating non-small cell lung cancer. Wen Luo, Nicholas J. Schork, Keith B. Marschke, PubMed	2011	25

Page 1